Bone marrow dosimetry in peptide receptor radionuclide therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate

PURPOSE: Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therapy (PRRT). Besides the kidneys, the bone marrow is a potentially dose-limiting organ. The radiation dose to the bone marrow is usually calculated according to the MIRD scheme, where the accumulated act...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Forrer, Flavio, Krenning, Eric P., Kooij, Peter P., Bernard, Bert F., Konijnenberg, Mark, Bakker, Willem H., Teunissen, Jaap J. M., de Jong, Marion, van Lom, Kirsten, de Herder, Wouter W., Kwekkeboom, Dik J.
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2009
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2691529/
https://ncbi.nlm.nih.gov/pubmed/19247653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-009-1072-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars